Literature DB >> 21239875

Release the ink4a/arf growth suppression by "u" and "me"?

Shuo Qie, Nianli Sang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21239875      PMCID： PMC3233482          DOI： 10.4161/cc.10.2.14471

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  44 in total

1.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

Authors:  M Esteller; S Tortola; M Toyota; G Capella; M A Peinado; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

3.  BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.

Authors:  Javier Briones; John M Timmerman; David M Hilbert; Ronald Levy
Journal:  Exp Hematol       Date:  2002-02       Impact factor: 3.084

4.  c-myc is a downstream target of the Smad pathway.

Authors:  Ken Yagi; Masao Furuhashi; Hiromasa Aoki; Daisuke Goto; Hiroyuki Kuwano; Kazuo Sugamura; Kohei Miyazono; Mitsuyasu Kato
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

5.  Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells.

Authors:  Stanislav Zelivianski; Anne Cooley; Ron Kall; Jacqueline S Jeruss
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

6.  Cyclin E and survival in patients with breast cancer.

Authors:  Khandan Keyomarsi; Susan L Tucker; Thomas A Buchholz; Matthew Callister; Ye Ding; Gabriel N Hortobagyi; Isabelle Bedrosian; Christopher Knickerbocker; Wendy Toyofuku; Michael Lowe; Thaddeus W Herliczek; Sarah S Bacus
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

7.  Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines.

Authors:  Anne Cooley; Stanislav Zelivianski; Jacqueline S Jeruss
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

8.  CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation.

Authors:  Vivian Chen; Emma Shtivelman
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

9.  An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.

Authors:  Lan V Pham; Archito T Tamayo; Changping Li; Carlos Bueso-Ramos; Richard J Ford
Journal:  Blood       Date:  2010-07-27       Impact factor: 22.113

10.  A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland.

Authors:  Ethan A Kohn; Zhijun Du; Misako Sato; Catherine M H Van Schyndle; Michael A Welsh; Yu-an Yang; Christina H Stuelten; Binwu Tang; Wenjun Ju; Erwin P Bottinger; Lalage M Wakefield
Journal:  Breast Cancer Res       Date:  2010-10-13       Impact factor: 6.466
View more
  1 in total

1.  ETV1 positively regulates transcription of tumor suppressor ARF.

Authors:  Evan Zynda; Mark W Jackson; Partho Bhattacharya; Eugene S Kandel
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.